While we were unable to determine a role for GPATCH2 in the control of Tnf expression, it would be interesting to assess the impact of the loss of GPATCH2 in the context of breast cancer and NF-κB activation, as this may uncover a role for GPATCH2 in vivo. This evidence concerns the gene NFKB1 and breast cancer.